FDA black box warnings: characteristics of drug classes and adverse effects

Signal detection of drug-induced esophageal ulcer across 20 years of real-world study: Focus on 49 high-risk medicines

Artificial Intelligence for Adverse Drug Event Prediction: Integrative Multi-Modal Modeling, Clinical Translation, and Regulatory Alignment in Pharmacovigilance

Un joven de Zamora crea una app con IA que puede evitar errores con medicamentos

MHRA action boosts drive to phase out animal testing

Research progress on the intrinsic link between the occurrence and progression of malignant tumors, chronic kidney disease and drug safety

No hay una alerta sanitaria en España por medicamentos con fenilpropalamina: es un bulo de WhatsApp

Pharmacovigilance capacity and readiness of vaccine manufacturers in low- and middle-income countries: a maturity-based assessment of the pharmacovigilance system

Pharmacovigilance and Adverse Drug Reaction Reporting: Regulatory Framework, Challenges, and Future Perspectives.

Machine learning studies of drug-induced nephrotoxicity: a scoping review

Risk factors for drug-related ischemic stroke: an analysis of the FDA adverse event reporting system (FAERS)

Real-world pharmacovigilance of tobramycin/dexamethasone: A safety signal analysis using the the Food and Drug Administration Adverse Event Reporting System (FAERS)

La AEMPS publica el Informe Anual del Sistema Español de Farmacovigilancia de Medicamentos de Uso Humano

Hidden antibiotics in river fish spark new food safety fears

Alerta por presencia de sildenafilo en complemento alimenticio. (Ref. ES2026/148)

¿Es la grasa visceral un marcador de toxicidad por metotrexato en población pediátrica con leucemia?

Determinants and outcomes of adverse drug reactions among people living with HIV on antiretroviral therapy in Nigeria

Prevalence of severe fatigue after SARS-CoV-2 infection in Norway: a prospective 2-year follow-up study

Hydralazine Use and Risk of Vasculitis

Incidence of Adverse Events in Peripheral Intravenous Vasopressor Use. A Systematic Review and Meta-Analysis

Molecular mechanisms and clinical patterns of ICI-associated acute kidney failure: an integrated pharmacovigilance and pathway analysis

The Mark of Confusion: Untangling the Circuit Split in Trademark Infringement Jurisprudence

Incidence and trends of adverse drug reactions during seasonal malaria chemoprevention among children: evidence from Ghana's pharmacovigilance database, 2015-2023

A dataset of medication images with instance segmentation masks for preventing adverse drug events

Recommendations to Enable Broader Use of Real-World Evidence to Inform Decision-Making Throughout Pharmacovigilance Signal Management

Charting and Sidestepping the Pitfalls of Disproportionality Analysis

Med Op-Ed: TAVR Safety Signal, Limits of Famed Biobank, & More

Identification of Drug Repurposing Opportunities of Immunomodulatory Drugs for Inflammatory Bowel Disease Through Inverse Pharmacovigilance Signal Detection in the FAERS Database

Barriers and facilitators to implementing a shared decision-making tool for anticoagulant-related drug–drug interactions: a qualitative study across three academic medical centres in the USA

The boom in counterfeit obesity drugs

Detection of Illicit Content on Online Marketplaces using Large Language Models

Adverse events associated with use of immunoglobulin in pediatric patients reported to the US Food and Drug Administration Adverse Event Reporting System, 2001-2023

Economic evaluation of anti-malarial drug policies across presidential regimes in Nigeria: A comparative analysis from 1999 to present

Virological Failure on Long-Acting Injectable Cabotegravir and Rilpivirine: An Analysis of Subtypes, Drug Levels, Resistance, and Therapeutic Implications

Early Identification of Cardiovascular Adverse Events Associated With Rofecoxib Using Real‐World Data From the UK: A Nested Case–Control and Case‐Crossover Study

Trends and Patterns of Adverse Drug Reaction Reporting in Sierra Leone: A Retrospective Analysis of VigiFlow Data (2008–2022)

Preventability of Antibiotic-Associated Adverse Drug Reactions Reported to a Regional Pharmacovigilance Center: A Cross-Sectional Descriptive Study

Adverse Childhood Experiences and Treatment-Resistant Depression

Meningitis Risk for Young Adults With Chikungunya Vaccine

INFORME RACIM. Actualización sobre medicamentos retirados por motivos de seguridad en otros países y su permanencia en Argentina